InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Lewicki John A.. Officer active across 2 companies, notably Mereo BioPharma Group plc. Cumulatively, 7 reports have been published. Split: 0 buy · 5 sells. Total volume traded: €47k. History available since 21 June 2024. The latest transaction was disclosed on 12 September 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Lewicki John A. is a declarant linked to Mereo BioPharma Group plc, where he is Chief Scientific Officer, and to OncoMed Pharmaceuticals Inc, where he is EVP & Chief Scientific Officer. He has 7 filings in total. Among the 7 most recent sampled filings, there were no purchases and 46622 euros of sales, over the period from 2016-01-08 to 2024-09-16, with a modal transaction nature of Cession.